Manuela C. Carvalho

Porto, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

ImpaHCta-Haemophilia Carriers Quality of Life Assessment.

ImpaHCta-Haemophilia Carriers Quality of Life Assessment.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: January 22, 2025

Switching hemophilia A patients to rVIII-SingleChain: The Iberian experience.

Switching hemophilia A patients to rVIII-SingleChain: The Iberian experience.

Journal: Medicine

Published: September 10, 2024

Blood Group O Does Not Increase the Risk of Inhibitors in Severe Haemophilia A: Data from the PedNet Study Group.

Blood Group O Does Not Increase the Risk of Inhibitors in Severe Haemophilia A: Data from the PedNet Study Group.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: August 26, 2024

Extension Study With rVIII-SingleChain in Previously Untreated Patients (PUPs) With Severe Haemophilia A.

Extension Study With rVIII-SingleChain in Previously Untreated Patients (PUPs) With Severe Haemophilia A.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: July 02, 2024

Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect study.

Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect study.

Journal: European journal of haematology

Published: March 17, 2023

Prevalence of COVID-19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from Europe.

Prevalence of COVID-19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from Europe.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: October 25, 2022

Different inhibitor incidence for individual factor VIII concentrates in 1076 previously untreated patients with severe hemophilia A: data from the PedNet cohort.

Different inhibitor incidence for individual factor VIII concentrates in 1076 previously untreated patients with severe hemophilia A: data from the PedNet cohort.

Journal: Journal of thrombosis and haemostasis : JTH

Published: August 18, 2022

Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A - A modified Delphi consensus by the ADVANCE Working Group.

Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A - A modified Delphi consensus by the ADVANCE Working Group.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: July 01, 2022

New Inhibitors in the Ageing Population: A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with Hemophilia.

New Inhibitors in the Ageing Population: A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with Hemophilia.

Journal: Thrombosis and haemostasis

Published: September 10, 2021

Quality of life in a large multinational haemophilia B cohort (The B-Natural study) - Unmet needs remain.

Quality of life in a large multinational haemophilia B cohort (The B-Natural study) - Unmet needs remain.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: June 11, 2021

Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study.

Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study.

Journal: Thrombosis and haemostasis

Published: February 13, 2021

Effectiveness of hypnosis for pain and health-related quality-of-life among people with hemophilia: Three-month outcomes of a randomized controlled pilot trial.

Effectiveness of hypnosis for pain and health-related quality-of-life among people with hemophilia: Three-month outcomes of a randomized controlled pilot trial.

Journal: Complementary therapies in clinical practice

Published: December 18, 2020

Showing 1-12 of 23

Last Updated: 09/26/2026